Roche Holding AG Cash Flow Conversion Efficiency

Latest as of June 2026: 0.195x

Roche Holding AG cash flow conversion efficiency. Based on the latest financial reports, Roche Holding AG (RO) has a cash flow conversion efficiency ratio of 0.195x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CHF7.17 Billion ≈ $9.06 Billion USD) by net assets (CHF36.72 Billion ≈ $46.42 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Roche Holding AG (1998–2025)

Cash flow conversion efficiency of Roche Holding AG from 1998 to 2025. This chart illustrates how Roche Holding AG's cash flow conversion efficiency has evolved over time, based on yearly financial data. View today's stock price for Roche Holding AG for real-time trading data and today's change.

Roche Holding AG Cash Flow Conversion Ratio Explained

Roche Holding AG cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Roche Holding AG Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Roche Holding AG ranked by their cash flow conversion efficiency. Also see how much is Roche Holding AG worth for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
Devon Energy Corporation NYSE:DVN	0.108x
Societe Generale S.A. PA:GLE	-0.332x
Wheaton Precious Metals Corp TO:WPM	0.067x
Life Insurance Corporation Of India NSE:LICI	0.034x
PACCAR Inc NASDAQ:PCAR	0.049x
DSV Panalpina A/S CO:DSV	0.049x
Realty Income Corporation NYSE:O	0.021x
LG Energy Solution Ltd KO:373220	-0.011x

Annual Cash Flow Conversion Efficiency for Roche Holding AG (1998–2025)

The table below shows the annual cash flow conversion efficiency of Roche Holding AG from 1998 to 2025. Review RO free cash flow generation to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CHF37.88 Billion ≈ $47.89 Billion	CHF17.83 Billion ≈ $22.54 Billion	0.471x	-15.29%
2024-12-31	CHF36.16 Billion ≈ $45.72 Billion	CHF20.09 Billion ≈ $25.40 Billion	0.556x	+14.84%
2023-12-31	CHF33.26 Billion ≈ $42.05 Billion	CHF16.09 Billion ≈ $20.35 Billion	0.484x	-15.88%
2022-12-31	CHF32.02 Billion ≈ $40.48 Billion	CHF18.41 Billion ≈ $23.28 Billion	0.575x	-22.27%
2021-12-31	CHF28.34 Billion ≈ $35.84 Billion	CHF20.98 Billion ≈ $26.52 Billion	0.740x	+58.53%
2020-12-31	CHF39.77 Billion ≈ $50.28 Billion	CHF18.57 Billion ≈ $23.47 Billion	0.467x	-25.21%
2019-12-31	CHF35.87 Billion ≈ $45.35 Billion	CHF22.39 Billion ≈ $28.30 Billion	0.624x	-5.14%
2018-12-31	CHF30.37 Billion ≈ $38.39 Billion	CHF19.98 Billion ≈ $25.26 Billion	0.658x	+5.89%
2017-12-31	CHF29.01 Billion ≈ $36.67 Billion	CHF18.02 Billion ≈ $22.79 Billion	0.621x	+9.36%
2016-12-31	CHF26.40 Billion ≈ $33.38 Billion	CHF15.00 Billion ≈ $18.97 Billion	0.568x	-13.20%
2015-12-31	CHF23.30 Billion ≈ $29.46 Billion	CHF15.25 Billion ≈ $19.28 Billion	0.655x	-11.42%
2014-12-31	CHF21.56 Billion ≈ $27.26 Billion	CHF15.93 Billion ≈ $20.14 Billion	0.739x	-0.48%
2013-12-31	CHF21.24 Billion ≈ $26.85 Billion	CHF15.77 Billion ≈ $19.94 Billion	0.743x	-17.22%
2012-12-31	CHF16.73 Billion ≈ $21.15 Billion	CHF15.01 Billion ≈ $18.97 Billion	0.897x	+0.28%
2011-12-31	CHF14.48 Billion ≈ $18.31 Billion	CHF12.95 Billion ≈ $16.38 Billion	0.894x	-27.27%
2010-12-31	CHF11.66 Billion ≈ $14.74 Billion	CHF14.34 Billion ≈ $18.13 Billion	1.230x	-31.40%
2009-12-31	CHF9.41 Billion ≈ $11.90 Billion	CHF16.88 Billion ≈ $21.34 Billion	1.793x	+692.39%
2008-12-31	CHF53.82 Billion ≈ $68.05 Billion	CHF12.18 Billion ≈ $15.40 Billion	0.226x	+2.83%
2007-12-31	CHF53.31 Billion ≈ $67.39 Billion	CHF11.73 Billion ≈ $14.83 Billion	0.220x	-0.29%
2006-12-31	CHF46.81 Billion ≈ $59.19 Billion	CHF10.33 Billion ≈ $13.06 Billion	0.221x	-7.67%
2005-12-31	CHF41.74 Billion ≈ $52.77 Billion	CHF9.97 Billion ≈ $12.61 Billion	0.239x	+8.46%
2004-12-31	CHF33.29 Billion ≈ $42.09 Billion	CHF7.33 Billion ≈ $9.27 Billion	0.220x	-11.41%
2003-12-31	CHF29.16 Billion ≈ $36.87 Billion	CHF7.25 Billion ≈ $9.17 Billion	0.249x	+552.72%
2002-12-31	CHF25.77 Billion ≈ $32.58 Billion	CHF982.00 Million ≈ $1.24 Billion	0.038x	-74.64%
2001-12-31	CHF33.87 Billion ≈ $42.82 Billion	CHF5.09 Billion ≈ $6.43 Billion	0.150x	+22.90%
2000-12-31	CHF32.04 Billion ≈ $40.50 Billion	CHF3.92 Billion ≈ $4.95 Billion	0.122x	+112.35%
1999-12-31	CHF30.00 Billion ≈ $37.93 Billion	CHF1.73 Billion ≈ $2.18 Billion	0.058x	-63.69%
1998-12-31	CHF22.82 Billion ≈ $28.84 Billion	CHF3.62 Billion ≈ $4.57 Billion	0.159x	--

About Roche Holding AG

SW:RO Switzerland Drug Manufacturers - General

Market Cap

$53.82 Billion

CHF42.57 Billion CHF

Market Cap Rank

#499 Global

#9 in Switzerland

Share Price

CHF399.00

Change (1 day)

-1.87%

52-Week Range

CHF276.40 - CHF411.20

All Time High

CHF411.20